COVID-19 Mortality Higher With COPD and Smoking, Study Finds

News
Article

Results of a PLOS ONE study determined a positive relationship between COPD and smoking and mortality rates from COVID-19.

Results of a new study published in PLOS ONE found a correlation between high mortality rates from coronavirus disease 2019 (COVID-19) and individuals who currently smoke and are diagnosed with chronic obstructive pulmonary disease (COPD).

The study, co-published by Jaber Alqahtani, PhD, determined this association by searching databases of scientific literature to find publications on conditions similar to those found in victims of COVID-19, as well as the prevalence of COPD in patients with COVID-19. Of 15 research papers with reports on 2473 patients with COVID-19 , 58 (2.3%) were diagnosed with COPD, and 221 (9%) as smokers.

One of the most common symptoms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is dysfunction of the respiratory system. Individuals with COPD experience similar effects, and given this similarity, the team wanted to see if there was a clear correlation between the condition and the virus.

The study determined that patients with COPD who were critically ill with COVID-19 had a 63% risk of severe disease and a 60% risk of mortality; meanwhile, patients with COVID-19 without COPD had a 33.4% risk of severe disease and 55% risk of mortality. Current smokers showed a risk of 22% of contracting severe complications, as did 46% of ex-smokers. Current smokers also exhibited a 38.5% mortality rate, according to the study.

Despite these percentages, the study investigators were unable to determine an association between the frequency of COPD exacerbations, or severity of COPD, with COVID-19 complications, primarily because COPD was low in reports of COVID-19 cases. Other hinderances were the diversity of locations, settings, and designs of the 15 studies.

References

  1. COPD and smoking associated with higher COVID-19 mortality. News Release. ScienceDaily; May 11, 2020. Accessed June 23, 2020. https://www.sciencedaily.com/releases/2020/05/200511142146.htm
  2. Alqahtani JS, Oyelade T, Aldhahir AM, et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: A rapid systematic review and meta-analysis. PLOS ONE. 2020; 15(5): e0233147. https://doi.org/10.1371/journal.pone.0233147

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos
© 2025 MJH Life Sciences

All rights reserved.